David M. Reese
Executive Vice President And Chief Technology Officer
Amgen Inc. · AMGN
$8.3M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed April 7, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1.3M
- Stock Awards
- $3.4M
- Option Awards
- $1.4M
- Incentives
- $1.8M
- Other
- $416K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,306,721 | $3,359,787 | $8,290,308 |
| 2024 | $1,268,615 | $3,359,613 | $8,126,822 |
| 2023 | $1,212,823 | $3,149,928 | $7,902,655 |
Current Position
- Company
- Amgen Inc.
- Title
- Executive Vice President And Chief Technology Officer
- Ticker
- AMGN · NASDAQ
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed April 7, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0001193125-26-145588.
Other Amgen Executives
Robert A. Bradway
Chief Executive Officer And President
Amgen · AMGN
$24.7M
FY 2025 · DEF 14A
Peter H. Griffith
Executive Vice President And Chief Financial Officer
Amgen · AMGN
$8.6M
FY 2025 · DEF 14A
Murdo Gordon
Executive Vice President, Global Commercial Operations
Amgen · AMGN
$8.5M
FY 2025 · DEF 14A
James E. Bradner
Executive Vice President, Research And Development
Amgen · AMGN
$8.6M
FY 2025 · DEF 14A